HomeCompareCINC vs QYLD

CINC vs QYLD: Dividend Comparison 2026

CINC yields 6.88% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CINC wins by $6.1K in total portfolio value
10 years
CINC
CINC
● Live price
6.88%
Share price
$29.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.5K
Annual income
$1,065.72
Full CINC calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — CINC vs QYLD

📍 CINC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCINCQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CINC + QYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CINC pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CINC
Annual income on $10K today (after 15% tax)
$585.00/yr
After 10yr DRIP, annual income (after tax)
$905.86/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, QYLD beats the other by $3,904.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CINC + QYLD for your $10,000?

CINC: 50%QYLD: 50%
100% QYLD50/50100% CINC
Portfolio after 10yr
$28.5K
Annual income
$3,362.52/yr
Blended yield
11.81%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CINC right now

CINC
Analyst Ratings
4
Buy
3
Hold
Consensus: Buy
Price Target
$48.50
+66.9% upside vs current
Range: $30.00 — $73.00
Altman Z
75.2
Piotroski
2/9
QYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CINC buys
0
QYLD buys
0
No recent congressional trades found for CINC or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCINCQYLD
Forward yield6.88%11.92%
Annual dividend / share$2.00$2.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$31.5K$25.4K
Annual income after 10y$1,065.72$5,659.31
Total dividends collected$8.8K$27.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: CINC vs QYLD ($10,000, DRIP)

YearCINC PortfolioCINC Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$11,388$688.23$10,352$1,192.36+$1.0KCINC
2$12,918$732.50$10,830$1,347.57+$2.1KCINC
3$14,599$776.53$11,460$1,539.07+$3.1KCINC
4$16,441$820.16$12,275$1,777.84+$4.2KCINC
5$18,455$863.22$13,323$2,078.95+$5.1KCINC
6$20,652$905.58$14,667$2,463.34+$6.0KCINC
7$23,045$947.11$16,396$2,960.57+$6.6KCINC
8$25,646$987.70$18,631$3,612.97+$7.0KCINC
9$28,468$1,027.26$21,548$4,482.15+$6.9KCINC
10$31,527$1,065.72$25,398$5,659.31+$6.1KCINC

CINC vs QYLD: Complete Analysis 2026

CINCStock

CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of treatments for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases. CinCor Pharma, Inc. has a license agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. The company was incorporated in 2018 and is headquartered in Boston, Massachusetts.

Full CINC Calculator →

QYLDETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this CINC vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CINC vs SCHDCINC vs JEPICINC vs OCINC vs KOCINC vs MAINCINC vs XYLDCINC vs JEPQCINC vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.